CRL · Charles River Laboratories International, Inc. · Executive Compensation
$315.45
+15.43 (+5.14%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$15.06B
Shares
47.74M
Volume · Oct 20
1.27M
Avg daily vol (3M)
943.43K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael Knell | Senior Vice President, Chief Accounting Officer & Interim Chief Financial Officer | $2,107,684 |
| Michael G. Knell | Senior Vice President, Chief Accounting Officer & Interim Chief Financial Officer | $2,107,684 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| James Foster | Chair, President, Chief Executive Officer and Director | $13,473,609 |
| James C. Foster | Chair, President, Chief Executive Officer and Director | $13,473,609 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $5,056,475 |
| Flavia Pease | Corporate Executive Vice President, Chief Financial Officer | $3,154,246 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $2,980,959 |
| Victoria Creamer | Corporate Executive Vice President, Chief People Officer | $2,806,632 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James C. Foster | Chair, President, Chief Executive Officer and Director | $14,096,924 |
| James Foster | Chair, President, Chief Executive Officer and Director | $14,096,924 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $4,989,672 |
| Flavia Pease | Corporate Executive Vice President, Chief Financial Officer | $3,811,326 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $3,058,456 |
| William D. Barbo | Corporate Executive Vice President | $2,908,735 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| James Foster | Chair, President, Chief Executive Officer and Director | $13,447,872 |
| James C. Foster | Chair, President, Chief Executive Officer and Director | $13,447,872 |
| Flavia Pease | Corporate Executive Vice President, Chief Financial Officer | $4,484,150 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $4,165,529 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $2,905,945 |
| William D. Barbo | Corporate Executive Vice President | $2,762,209 |
| David Smith | Former Corporate Executive Vice President and Chief Financial Officer | $2,172,415 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James C. Foster | Chair, President, Chief Executive Officer and Director | $13,705,581 |
| James Foster | Chair, President, Chief Executive Officer and Director | $13,705,581 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $7,917,700 |
| David Smith | Former Corporate Executive Vice President and Chief Financial Officer | $3,611,028 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $3,196,674 |
| William D. Barbo | Corporate Executive Vice President | $2,846,219 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| James Foster | Chairman, President, Chief Executive Officer and Director | $13,483,411 |
| James C. Foster | Chairman, President, Chief Executive Officer and Director | $13,483,411 |
| David Smith | Former Corporate Executive Vice President and Chief Financial Officer | $3,113,563 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $2,724,866 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $2,646,443 |
| William D. Barbo | Corporate Executive Vice President, Chief Commercial Officer | $2,609,475 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| James C. Foster | Chair, President, Chief Executive Officer and Director | $17,722,105 |
| James Foster | Chair, President, Chief Executive Officer and Director | $17,722,105 |
| David P. Johst | Corporate Executive Vice President, General Counsel and Chief Administrative Officer | $6,566,852 |
| David Smith | Corporate Executive Vice President and Chief Financial Officer | $3,507,299 |
| Joseph LaPlume | Corporate Executive Vice President Corporate Development and Strategy | $3,009,509 |
| Birgit Girshick | Corporate Executive Vice President, Chief Operating Officer | $2,988,001 |
| William D. Barbo | Corporate Executive Vice President, Chief Commercial Officer | $2,962,196 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| James Foster | Chairman, President, Chief Executive Officer and Director | $14,450,801 |
| James C. Foster | Chairman, President, Chief Executive Officer and Director | $14,450,801 |
| David P. Johst | Corporate Executive Vice President, General Counsel and Chief Administrative Officer | $5,269,398 |
| David Smith | Corporate Executive Vice President and Chief Financial Officer | $3,239,941 |
| William D. Barbo | Corporate Executive Vice President, Chief Commercial Officer | $2,576,389 |
| Birgit Girshick | Corporate Executive Vice President, Discovery and | $2,523,356 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| James Foster | Chairman, President, Chief Executive Officer and Director | $12,575,597 |
| James C. Foster | Chairman, President, Chief Executive Officer and Director | $12,575,597 |
| David P. Johst | Corporate Executive Vice President, General Counsel and Chief Administrative Officer | $4,609,709 |
| David Smith | Corporate Executive Vice President and Chief Financial Officer | $2,602,563 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Martin W. Mackay | director | Appointed | 2026-05-11 |
| Virginia M. Wilson | director | Appointed | 2026-05-11 |
| Craig B. Thompson | director | Appointed | 2026-05-11 |
| James C. Foster | director | Appointed | 2026-05-11 |
| George Llado, Sr. | director | Appointed | 2026-05-11 |
| Reshema Kemps-Polanco | director | Appointed | 2026-05-11 |
| Mark Enyedy | director | Appointed | 2026-05-11 |
| Paul Graves | director | Appointed | 2026-05-11 |
| Birgit Girshick | director | Appointed | 2026-05-11 |
| Abraham Ceesay | director | Appointed | 2026-05-11 |
| Steven Barg | director | Appointed | 2026-05-11 |
| Nancy C. Andrews | director | Appointed | 2026-05-11 |
| Glenn Coleman | Corporate Executive Vice President and Chief Financial Officer | Appointed | 2026-02-18 |
| Martin Mackay | Chair of the Board | Appointed | 2026-01-09 |
| Birgit Girshick | Chief Executive Officer | Appointed | 2026-01-09 |
| Michael G. Knell | interim Chief Financial Officer | Appointed | 2025-09-16 |
| Flavia H. Pease | Corporate Executive Vice President, Chief Financial Officer | Resigned | 2025-09-16 |
| Paul Graves | to the Board | Appointed | 2025-05-23 |
| Abraham Ceesay | to the Board | Appointed | 2025-05-23 |
| Mark Enyedy | to the Board | Appointed | 2025-05-23 |
| Steven Barg | to the Board | Appointed | 2025-05-23 |
| Abe Ceesay | Director | Appointed | 2025-05-07 |
| Paul Graves | New Company Director | Appointed | 2025-05-07 |
| Mark Enyedy | Investor Designated Director | Appointed | 2025-05-07 |
| Abraham Ceesay | New Company Director | Appointed | 2025-05-07 |
Leadership
- Abraham Ceesay CEO, Board Member
- Craig B. Thompson CEO, Board Member
- James C. Foster CEO, Board Member
- James Foster CEO, Board Member
- Mark Enyedy CEO, Board Member
- Martin W. Mackay CEO, Board Member
- Paul Graves CEO, Board Member
- Reshema Kemps-Polanco CEO, Board Member
- George M. Milne Chairman
- Martin Mackay Chairman
- Michael G. Knell CFO
- Virginia M. Wilson CFO, Board Member
- Birgit Girshick COO, Board Member
- George E. Massaro COO
- George Llado CIO, Board Member
- David P. Johst General Counsel
- Abe Ceesay Board Member
- Dr. Craig B. Thompson Board Member
- George Llado Sr. Board Member
- George Llado, Sr. Board Member
- Nancy C. Andrews Board Member
- Nancy C. Andrews, M.D., Ph.D. Board Member
- Steven Barg Board Member
Key facts
CIK
1100682
CUSIP
159864107
13F (30d)
84 filings
77 filers
Visit website
Investor relations